Lisinopril
- Product NDC
- 62135-643
- 11-digit product format
- 621350643
- Labeler code
- 62135
- Product ID
- 62135-643_462a5023-e5a0-692a-e063-6294a90a7236
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA208920
- Marketing category
- ANDA
- Marketing start
- 2021-03-04
- Substance
- LISINOPRIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lisinopril
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LISINOPRIL | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | E7199S1YWR |
| Rxcui | 197884, 205326, 311353, 311354, 314076, 314077 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-643-31 | Lisinopril | 300 in 1 BOTTLE | TABLET | 300 | | 3 |
| 62135-643-90 | Lisinopril | 90 in 1 BOTTLE | TABLET | 90 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-643 | LISINOPRIL TABLET [CHARTWELL RX, LLC] | 2 | Current NDC, 2 package rows | 20241013_8824e5e5-ed35-4a95-bfd6-98a2e7c4bbce.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-643-31 | 62135064331 | 300 TABLET in 1 BOTTLE (62135-643-31) | 300 tablet | 2023-06-07 | No | No | Current |
| 62135-643-90 | 62135064390 | 90 TABLET in 1 BOTTLE (62135-643-90) | 90 tablet | 2023-06-07 | No | No | Current |